Global GM1 Gangliosidosis market size is expected to reach $0.96 billion by 2030 at 10.8%, rising adoption of gene therapy fuels growth in rare disease treatments
Read More
Global Nontuberculous Mycobacterial Infection market size is expected to reach $21.01 billion by 2030 at 7.3%, segmented as by macrolides, azithromycin, clarithromycin
Read More
Global Glycomics or Glycobiology market size is expected to reach $4.66 billion by 2030 at 17%, glycomics and glycobiology market driven by increased demand for chronic disease medications
Read More
Global Glycomic Therapeutics market size is expected to reach $424.67 billion by 2030 at 17.6%, rising diabetes prevalence fuels growth in the glycomic therapeutics market
Read More
The non-surgical cosmetic procedures market is projected to reach $47.37 billion by 2030, growing at 10.5% CAGR, driven by injectables, energy-based devices, and personalized aesthetics.
Read More
Global Glucagon-Like Peptide (GLP)-1 Agonists Weight Loss Drugs market size is expected to reach $32.87 by 2030 at 16.2%, rising prevalence of obesity fueling the growth of the market due to increasing demand
Read More
Global Glomerulonephritis market size is expected to reach $14.66 billion by 2030 at 4.7%, rising prevalence of kidney disorders driving the market growth
Read More
Global Non-Small Cell Lung Cancer (NSCLC) market size is expected to reach $70.81 billion by 2030 at 11%, segmented as by squamous cell carcinoma, keratinizing squamous cell carcinoma, non-keratinizing squamous cell carcinoma
Read More
Global Gliosarcoma market size is expected to reach $1.6 billion by 2030 at 5%, rising incidence of brain tumors and the growing need for gliosarcoma treatment
Read More
The non-radiographic axial spondyloarthritis therapeutic market is projected to reach $1.72 billion by 2030, growing at 10.6% CAGR, driven by biologics, JAK inhibitors, and early intervention.
Read More